- Home
- FPI vs AQST Comparison
FPI vs AQST Comparison
Compare FPI & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FPI
- AQST
- Stock Information
- Founded
- FPI 2013
- AQST 2004
- Country
- FPI United States
- AQST United States
- Employees
- FPI N/A
- AQST N/A
- Industry
- FPI Real Estate Investment Trusts
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- FPI Real Estate
- AQST Health Care
- Exchange
- FPI Nasdaq
- AQST Nasdaq
- Market Cap
- FPI 478.7M
- AQST 390.4M
- IPO Year
- FPI 2014
- AQST 2018
- Fundamental
- Price
- FPI $10.92
- AQST $4.83
- Analyst Decision
- FPI
- AQST Strong Buy
- Analyst Count
- FPI 0
- AQST 7
- Target Price
- FPI N/A
- AQST $10.29
- AVG Volume (30 Days)
- FPI 275.3K
- AQST 2.3M
- Earning Date
- FPI 10-29-2025
- AQST 11-03-2025
- Dividend Yield
- FPI 2.17%
- AQST N/A
- EPS Growth
- FPI 229.01
- AQST N/A
- EPS
- FPI 1.21
- AQST N/A
- Revenue
- FPI $55,000,000.00
- AQST $44,132,000.00
- Revenue This Year
- FPI N/A
- AQST N/A
- Revenue Next Year
- FPI N/A
- AQST $38.71
- P/E Ratio
- FPI $9.17
- AQST N/A
- Revenue Growth
- FPI N/A
- AQST N/A
- 52 Week Low
- FPI $9.66
- AQST $2.12
- 52 Week High
- FPI $12.87
- AQST $5.80
- Technical
- Relative Strength Index (RSI)
- FPI 52.27
- AQST 58.87
- Support Level
- FPI $10.82
- AQST $4.75
- Resistance Level
- FPI $10.99
- AQST $5.27
- Average True Range (ATR)
- FPI 0.18
- AQST 0.30
- MACD
- FPI 0.03
- AQST 0.03
- Stochastic Oscillator
- FPI 62.99
- AQST 58.82
About FPI Farmland Partners Inc.
Farmland Partners Inc owns and seeks to acquire high-quality farmland throughout North America. The company is an internally managed real estate company which owns and contracts farmland and storage facilities located across the United States. Majority of the properties in its portfolio are used to grow primary crops, such as corn, soybeans, wheat, rice and cotton, and rest to produce specialty crops, such as almonds, pictachios, citrus, avacados, strawberies, and edible beans. The company generates its revenues through the rent it receives from its tenants.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.